what sort of hope do we have that if efficacy is ideal, we can progress to the next trial and skip a year?
A hope in hell? or am i daydreaming?
Interesting article on GT and pharma, page-20
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)